LP17276-4levoFLOXacinActive
Description
LP17276-4 levoFLOXacin
Levofloxacin is a bacteriacidal fluoroquinolone antibiotic that is effective against gram-positive and gram-negative organisms as well as other infectious agents, including Mycobacterium tuberculosis. It is used to treat a broad range of infections, including pneumonia, multi-drug resistant tuberculosis, and urinary tract infections. Levofloxacin increases the risk of tendinitis and tendon rupture, and is not recommended for children under the age of 18. [MedlinePlus Drug:a697040]
Source: Regenstrief LOINC, MedlinePlus Drug: Levofloxacin
Basic Part Properties
- Name
- levoFLOXacin
- Type
- Component
- Created On
- 2000-05-04
- Construct for LOINC Short Name
- levoFLOXacin
LOINC FHIR® API Example - CodeSystem Request Get Info
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP17276-4
Language Variants Get Info
- zh-CNChinese (China)
- 左氧氟沙星
Synonyms: 三环类氟喹诺酮类抗菌药;左旋氧氟沙星; 左氟沙星 - nl-NLDutch (Netherlands)
- levofloxacine
- et-EEEstonian (Estonia)
- Levofloksatsiin
- fr-BEFrench (Belgium)
- Lévofloxacine
- fr-CAFrench (Canada)
- Lévofloxacine
- it-ITItalian (Italy)
- Levofloxacina
- ru-RURussian (Russian Federation)
- Левофлоксацин
- es-ESSpanish (Spain)
- Levofloxacino
- tr-TRTurkish (Turkey)
- Levoflokzasin
LOINC Copyright
Copyright © 2022 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright